Literature DB >> 28982499

Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.

Phillip H Lam1, Daniel J Dooley1, Prakash Deedwania2, Steven N Singh3, Deepak L Bhatt4, Charity J Morgan5, Javed Butler6, Selma F Mohammed7, Wen-Chih Wu8, Gurusher Panjrath9, Michael R Zile10, Michel White11, Cherinne Arundel12, Thomas E Love13, Marc R Blackman14, Richard M Allman15, Wilbert S Aronow16, Stefan D Anker17, Gregg C Fonarow18, Ali Ahmed19.   

Abstract

BACKGROUND: A lower heart rate is associated with better outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). Less is known about this association in patients with HF with preserved ejection fraction (HFpEF).
OBJECTIVES: The aims of this study were to examine associations of discharge heart rate with outcomes in hospitalized patients with HFpEF.
METHODS: Of the 8,873 hospitalized patients with HFpEF (EF ≥50%) in the Medicare-linked OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry, 6,286 had a stable heart rate, defined as ≤20 beats/min variation between admission and discharge. Of these, 2,369 (38%) had a discharge heart rate of <70 beats/min. Propensity scores for discharge heart rate <70 beats/min, estimated for each of the 6,286 patients, were used to assemble a cohort of 2,031 pairs of patients with heart rate <70 versus ≥70 beats/min, balanced on 58 baseline characteristics.
RESULTS: The 4,062 matched patients had a mean age of 79 ± 10 years, 66% were women, and 10% were African American. During 6 years (median 2.8 years) of follow-up, all-cause mortality was 65% versus 70% for matched patients with a discharge heart rate <70 versus ≥70 beats/min, respectively (hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.80 to 0.93; p < 0.001). A heart rate <70 beats/min was also associated with a lower risk for the combined endpoint of HF readmission or all-cause mortality (HR: 0.90; 95% CI: 0.84 to 0.96; p = 0.002), but not with HF readmission (HR: 0.93; 95% CI: 0.85 to 1.01) or all-cause readmission (HR: 1.01; 95% CI: 0.95 to 1.08). Similar associations were observed regardless of heart rhythm or receipt of beta-blockers.
CONCLUSIONS: Among hospitalized patients with HFpEF, a lower discharge heart rate was independently associated with a lower risk of all-cause mortality, but not readmission. Published by Elsevier Inc.

Entities:  

Keywords:  all-cause mortality; all-cause readmission; atrial fibrillation; beta-blockers; propensity score

Mesh:

Substances:

Year:  2017        PMID: 28982499      PMCID: PMC8801201          DOI: 10.1016/j.jacc.2017.08.022

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  34 in total

1.  Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.

Authors:  Helen M Sheriff; Manik R Thogaripally; Gurusher Panjrath; Cherinne Arundel; Qing Zeng; Gregg C Fonarow; Javed Butler; Ross D Fletcher; Charity Morgan; Marc R Blackman; Prakash Deedwania; Thomas E Love; Wilbert S Aronow; Stefan D Anker; Richard M Allman; Ali Ahmed
Journal:  J Am Med Dir Assoc       Date:  2017-05-11       Impact factor: 4.669

2.  Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.

Authors:  Yan Zhang; Meredith L Kilgore; Tarun Arora; Marjan Mujib; O James Ekundayo; Inmaculada B Aban; Margaret A Feller; Ravi V Desai; Thomas E Love; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2011-11-25       Impact factor: 4.164

3.  Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.

Authors:  Michael R Zile; William H Gaasch; Inder S Anand; Markus Haass; William C Little; Alan B Miller; Jose Lopez-Sendon; John R Teerlink; Michel White; John J McMurray; Michel Komajda; Robert McKelvie; Agata Ptaszynska; Scott J Hetzel; Barry M Massie; Peter E Carson
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

4.  Heart rate predicts mortality in patients with heart failure and preserved systolic function.

Authors:  John R Kapoor; Paul A Heidenreich
Journal:  J Card Fail       Date:  2010-06-16       Impact factor: 5.712

5.  Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

Authors:  Dirk J van Veldhuisen; Alain Cohen-Solal; Michael Böhm; Stefan D Anker; Daphne Babalis; Michael Roughton; Andrew J S Coats; Philip A Poole-Wilson; Marcus D Flather
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

6.  Heart rate and cardiovascular mortality: the Framingham Study.

Authors:  W B Kannel; C Kannel; R S Paffenbarger; L A Cupples
Journal:  Am Heart J       Date:  1987-06       Impact factor: 4.749

7.  Retarding effect of lowered heart rate on coronary atherosclerosis.

Authors:  P A Beere; S Glagov; C K Zarins
Journal:  Science       Date:  1984-10-12       Impact factor: 47.728

8.  Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

Authors:  Gregg C Fonarow; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094

9.  Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.

Authors:  Kanan Patel; Gregg C Fonarow; O James Ekundayo; Inmaculada B Aban; Meredith L Kilgore; Thomas E Love; Dalane W Kitzman; Mihai Gheorghiade; Richard M Allman; Ali Ahmed
Journal:  Int J Cardiol       Date:  2014-03-11       Impact factor: 4.164

10.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2013-09-30       Impact factor: 2.373

View more
  13 in total

1.  The corrected left ventricular ejection fraction: a potential new measure of ventricular function.

Authors:  Jonathan Carl Luis Rodrigues; Benjamin Rooms; Katie Hyde; Stephen Rohan; Angus K Nightingale; Julian Paton; Nathan Manghat; Chiara Bucciarelli-Ducci; Mark Hamilton; Henggui Zhang; David H MacIver
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-22       Impact factor: 2.357

2.  Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.

Authors:  Amanda K Verma; Jie-Lena Sun; Adrian Hernandez; John R Teerlink; Phillip J Schulte; Justin Ezekowitz; Adriaan Voors; Randall Starling; Paul Armstrong; Christopher M O'Conner; Robert J Mentz
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

3.  Effects of a Higher Heart Rate on Quality of Life and Functional Capacity in Patients With Left Ventricular Diastolic Dysfunction.

Authors:  Kramer Wahlberg; Maren E Arnold; Daniel Lustgarten; Markus Meyer
Journal:  Am J Cardiol       Date:  2019-07-15       Impact factor: 2.778

4.  Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Apostolos Tsimploulis; Phillip H Lam; Cherinne Arundel; Steven N Singh; Charity J Morgan; Charles Faselis; Prakash Deedwania; Javed Butler; Wilbert S Aronow; Clyde W Yancy; Gregg C Fonarow; Ali Ahmed
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

5.  Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Essraa Bayoumi; Phillip H Lam; Daniel J Dooley; Steven Singh; Charles Faselis; Charity J Morgan; Samir Patel; Helen M Sheriff; Selma F Mohammed; Carlos E Palant; Bertram Pitt; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Med       Date:  2018-09-19       Impact factor: 4.965

Review 6.  How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure.

Authors:  Rose Mary Ferreira Lisboa da Silva; Anaisa Silva Roever Borges; Nilson Penha Silva; Elmiro Santos Resende; Gary Tse; Tong Liu; Leonardo Roever; Giuseppe Biondi-Zoccai
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

7.  Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.

Authors:  Charles Faselis; Cherinne Arundel; Samir Patel; Phillip H Lam; Stephen S Gottlieb; Michael R Zile; Prakash Deedwania; Gerasimos Filippatos; Helen M Sheriff; Qing Zeng; Charity J Morgan; Samuel Wopperer; Tran Nguyen; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  J Am Coll Cardiol       Date:  2020-08-11       Impact factor: 27.203

8.  Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction.

Authors:  Felix Hohendanner; Daniel Messroghli; David Bode; Florian Blaschke; Abdul Parwani; Leif-Hendrik Boldt; Frank R Heinzel
Journal:  ESC Heart Fail       Date:  2018-02-19

Review 9.  Heart failure with preserved ejection fraction: insights from recent clinical researches.

Authors:  Mi-Na Kim; Seong-Mi Park
Journal:  Korean J Intern Med       Date:  2020-04-29       Impact factor: 2.884

10.  Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.

Authors:  Min Soo Ahn; Byung Su Yoo; Jung Woo Son; Min Heui Yu; Dae Ryong Kang; Hae Young Lee; Eun Seok Jeon; Jae Joong Kim; Shung Chull Chae; Sang Hong Baek; Seok Min Kang; Dong Ju Choi; Kye Hun Kim; Myeong Chan Cho; Seong Yoon Kim
Journal:  J Korean Med Sci       Date:  2020-08-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.